Cancer Drugs Current Events | Cancer Drugs News | 3
|
| Page
3 of
135 |
2691 Results |
|
|
|
Sort By:
Page Views | Date |
Cancer Research director receives SCI accolade
9 July 2003, London, UK: Professor Sir David Lane, Director of the Cancer Research UK Transformation Research Group, will be awarded the Society of Chemical Industry (SCI) 2003 Society Medal today. The medal will be presented in recognition of his exceptional services to applied chemistry and the improvement of society at the 122nd Annual Meeting... view more... (2003-07-08)
Slipping past the blood brain barrier: Research shows potential treatment for brain cancer
A compound that kills cancer can sneak past the blood brain barrier, which protects the brain from foreign substances, to do its work in fighting a particularly invasive brain cancer. view more (2005-08-23)
Targeting lung cancer
As reported in the June 1 issue of G&D, Drs. Katerina Politi, Harold Varmus and colleagues at the Memorial Sloan Kettering Cancer Center in New York have developed a novel animal model of lung adenocarcinoma that will be of great use in testing the efficacy of targeted therapies against human lung cancer. view more (2006-05-18)
Inhibiting cell process may give cancer drug a boost
A molecule that interferes with the internal scaffolding that shapes the cell may kill cancer cells, retard the growth of tumors and give a boost to a common chemotherapy drug. view more (2006-05-04)
New Chemo Cocktail Blocks Breast Cancer Like a Fence
Think of a protective fence that blocks the neighbor's dog from charging into your backyard. The body, too, has fences -- physical and biochemical barriers that keep cells in their place. view more (2009-10-07)
New drugs boost for asbestos-related lung cancer sufferers
Clinical trials of a new anticancer drug combination carried out by researchers at Newcastle University show that it has potential to almost double the life expectancy of sufferers of Mesothelioma - a form of lung cancer which affects around 1,700 people in the UK every year - according to a report published in the Journal of Clinical Oncology.... view more... (2002-08-12)
Gene Test Could Reduce Unnecessary Treatment For Women With Breast Cancer (pp 340, 362)
In this week's issue of THE LANCET, US researchers describe how gene expression profiles could determine whether or not women with breast cancer would respond to docetaxel treatment. Women who are likely to be resistant to the drug could be given alternative treatment. Chemotherapy or hormonal treatment after surgery for breast cancer is crucial... view more... (2003-07-30)
Helicobacter pylori inhibits intercellular communication of cultured gastric cells
The formation of a cancer is proven to be a multi-stage, multi-mechanism process by animal and human studies. As a definite carcinogen, the role of Helicobacter pylori (H pylori) in the formation of gastric cancer has been unclear. view more (2007-10-29)
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease. view more (2009-09-24)
Lasers Penetrate Cancer's Gene Secrets
LIGHT SABRES and phaser guns may be the stuff of science fiction, but laser technology has brought an important step forward in our present-day understanding of cancer, a study reveals this week.* By using miniature lasers to probe pancreatic tumours, Cancer Research UK scientists have implicated three new genes in the development of the disease.... view more... (2002-07-04)
Researchers identify key gene that may be a marker of breast cancer metastasis
Researchers at Fox Chase Cancer Center have identified an important gene involved in the spread of breast cancer that has developed resistance to long-term estrogen deprivation. view more (2007-04-19)
Cancer Conundrum Cracked
Cancer researchers at the University of Dundee have just turned a common cancer belief on its head saying that a group of proteins previously believed to cause cancer can also be used in the fight against cancer. Dr Neil Perkins and his team in the School of Life Sciences have identified that NF-kappaB * a group of proteins present in every cell... view more... (2004-03-25)
Scientists identify two key genes linked to aggressive breast cancers
In a new study, scientists at The Hospital for Sick Children and Princess Margaret Hospital have shown that two genes called Notch1 and Jagged1 are linked to more aggressive breast cancers and that patients are less likely to survive the disease when these two genes are highly expressed. view more (2005-09-15)
Structures of marine toxins provide insight into their effectiveness as cancer drugs
Vibrantly colored creatures from the depths of the South Pacific Ocean harbor toxins that potentially can act as powerful anti-cancer drugs, according to research findings from University of Wisconsin-Madison biochemists and their Italian colleagues. view more (2005-09-27)
Scientists solve mystery of polyketide drug formation
Many top-selling drugs used to treat cancer and lower cholesterol are made from organic compounds called polyketides, which are found in nature but historically difficult for chemists to alter and reproduce in large quantities. view more (2008-04-02)
UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
Researchers at UCLA have successfully manipulated nanomaterials to create a new drug-delivery system that promises to solve the challenge of the poor water solubility of today's most promising anticancer drugs and thereby increase their effectiveness. view more (2007-06-08)
Treatments have same target, different responses for lung cancer patients with genetic mutation
The gene mutation that identifies the lung cancer patients most likely to respond to the drug gefitinib (Iressa) is not associated with a response to the drug cetuximab (Erbitux). view more (2005-08-17)
Outsmarting cancer - new results from novel enzyme inhibitors
Smart drugs that can break the chain of command between enzymes and the genes involved in cell division and cell death are a new way forward in tackling breast cancer, according to Dr Stephen Johnston, a consultant oncologist from The Royal Marsden Hospital, London, UK. He was speaking at a news briefing on Thursday (21 March) at the 3rd European... view more... (2002-03-19)
Discovery offers potential new pancreatic cancer treatment
Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed... view more... (2009-11-03)
Potential prostate cancer treatment improvements discovered by researchers at Cedars-Sinai
In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer. view more (2006-03-22)
|
|
| Page
3 of
135 |
2691 Results |
|
|
|
Sort By:
Page Views | Date |
|
